Industry: Chemical & Material
Published Date: 2026-01-08
Pages: 136 Pages
Report ld: 5599241
Request Sample
Customized Report
Human Peripheral Blood Lymphocyte Separation Medium Market Size(US$)

CAGR 2026-2032
5.1%
Market Size,2032
USD 215
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human Peripheral Blood Lymphocyte Separation Medium market was valued at US$ 153 million in 2025 and is anticipated to reach US$ 215 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Peripheral Blood Lymphocyte Separation Medium competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Human Peripheral Blood Lymphocyte Separation Medium is a solution used to separate lymphocytes from human peripheral blood. The main components include dextran (such as dextran) and diatrizoate meglumine (or polysucrose, diatrizoate, etc.). These components can form a density gradient, allowing lymphocytes to float at the interface between the density of blood and separation medium during centrifugation, thereby separating them from other cell components (such as red blood cells, platelets, etc.). The main purpose of the separation fluid is to separate mononuclear cells, mainly lymphocytes, from anticoagulated blood. These cells can be used for immunological testing, in vitro cell culture and other experiments, and have a wide range of applications in studying immune responses, vaccine development, and tumor immunotherapy.
The North American market for Human Peripheral Blood Lymphocyte Separation Medium is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Human Peripheral Blood Lymphocyte Separation Medium is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Human Peripheral Blood Lymphocyte Separation Medium include Merck, Thermo Fisher Scientific, Cytiva, Beyotime Biotechnology, Multi Sciences, Shanghai BasalMedia Technologies, Tianjin Haoyang Biological Manufacture, Dakewe Biotech, Guangzhou Jiance Biotechnology, CIDA (Guangzhou) Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Human Peripheral Blood Lymphocyte Separation Medium market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Peripheral Blood Lymphocyte Separation Medium. The Human Peripheral Blood Lymphocyte Separation Medium market size, estimates, and forecasts are provided in terms of shipments (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Peripheral Blood Lymphocyte Separation Medium market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Peripheral Blood Lymphocyte Separation Medium manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Human Peripheral Blood Lymphocyte Separation Medium manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Human Peripheral Blood Lymphocyte Separation Medium production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Human Peripheral Blood Lymphocyte Separation Medium consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human Peripheral Blood Lymphocyte Separation Medium Market Overview
1.1 Product Definition
1.2 Human Peripheral Blood Lymphocyte Separation Medium by Type
1.2.1 Global Human Peripheral Blood Lymphocyte Separation Medium Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Endotoxin <0.5EU
1.2.3 Endotoxin <0.25EU
1.3 Human Peripheral Blood Lymphocyte Separation Medium by Application
1.3.1 Global Human Peripheral Blood Lymphocyte Separation Medium Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Immune Response Research
1.3.3 Vaccine Development
1.3.4 Tumor Immunotherapy
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Human Peripheral Blood Lymphocyte Separation Medium Production Estimates and Forecasts (2021–2032)
1.4.4 Global Human Peripheral Blood Lymphocyte Separation Medium Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production Market Share by Manufacturers (2021–2026)
2.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Human Peripheral Blood Lymphocyte Separation Medium, Industry Ranking, 2024 vs 2025
2.4 Global Human Peripheral Blood Lymphocyte Separation Medium Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Human Peripheral Blood Lymphocyte Separation Medium Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Human Peripheral Blood Lymphocyte Separation Medium, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Human Peripheral Blood Lymphocyte Separation Medium, Product Offerings and Applications
2.8 Global Key Manufacturers of Human Peripheral Blood Lymphocyte Separation Medium, Date of Entry into the Industry
2.9 Human Peripheral Blood Lymphocyte Separation Medium Market Competitive Situation and Trends
2.9.1 Human Peripheral Blood Lymphocyte Separation Medium Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Human Peripheral Blood Lymphocyte Separation Medium Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Human Peripheral Blood Lymphocyte Separation Medium Production by Region
3.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Region (2021–2032)
3.2.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Human Peripheral Blood Lymphocyte Separation Medium by Region (2027–2032)
3.3 Global Human Peripheral Blood Lymphocyte Separation Medium Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Human Peripheral Blood Lymphocyte Separation Medium Production Volume by Region (2021–2032)
3.4.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Human Peripheral Blood Lymphocyte Separation Medium by Region (2027–2032)
3.5 Global Human Peripheral Blood Lymphocyte Separation Medium Market Price Analysis by Region (2021–2026)
3.6 Global Human Peripheral Blood Lymphocyte Separation Medium Production, Value, and Year-over-Year Growth
3.6.1 North America Human Peripheral Blood Lymphocyte Separation Medium Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Human Peripheral Blood Lymphocyte Separation Medium Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Human Peripheral Blood Lymphocyte Separation Medium Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Human Peripheral Blood Lymphocyte Separation Medium Production Value Estimates and Forecasts (2021–2032)
4 Human Peripheral Blood Lymphocyte Separation Medium Consumption by Region
4.1 Global Human Peripheral Blood Lymphocyte Separation Medium Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Human Peripheral Blood Lymphocyte Separation Medium Consumption by Region (2021–2032)
4.2.1 Global Human Peripheral Blood Lymphocyte Separation Medium Consumption by Region (2021–2026)
4.2.2 Global Human Peripheral Blood Lymphocyte Separation Medium Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Human Peripheral Blood Lymphocyte Separation Medium Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Human Peripheral Blood Lymphocyte Separation Medium Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Human Peripheral Blood Lymphocyte Separation Medium Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Human Peripheral Blood Lymphocyte Separation Medium Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Human Peripheral Blood Lymphocyte Separation Medium Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Human Peripheral Blood Lymphocyte Separation Medium Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Human Peripheral Blood Lymphocyte Separation Medium Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Human Peripheral Blood Lymphocyte Separation Medium Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production by Type (2021–2032)
5.1.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production by Type (2021–2026)
5.1.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production by Type (2027–2032)
5.1.3 Global Human Peripheral Blood Lymphocyte Separation Medium Production Market Share by Type (2021–2032)
5.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Type (2021–2032)
5.2.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Type (2021–2026)
5.2.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Type (2027–2032)
5.2.3 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value Market Share by Type (2021–2032)
5.3 Global Human Peripheral Blood Lymphocyte Separation Medium Price by Type (2021–2032)
6 Segment by Application
6.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production by Application (2021–2032)
6.1.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production by Application (2021–2026)
6.1.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production by Application (2027–2032)
6.1.3 Global Human Peripheral Blood Lymphocyte Separation Medium Production Market Share by Application (2021–2032)
6.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Application (2021–2032)
6.2.1 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Application (2021–2026)
6.2.2 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value by Application (2027–2032)
6.2.3 Global Human Peripheral Blood Lymphocyte Separation Medium Production Value Market Share by Application (2021–2032)
6.3 Global Human Peripheral Blood Lymphocyte Separation Medium Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Merck
7.1.1 Merck Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.1.2 Merck Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.1.3 Merck Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Merck Main Business and Markets Served
7.1.5 Merck Recent Developments/Updates
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.2.2 Thermo Fisher Scientific Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.2.3 Thermo Fisher Scientific Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Thermo Fisher Scientific Main Business and Markets Served
7.2.5 Thermo Fisher Scientific Recent Developments/Updates
7.3 Cytiva
7.3.1 Cytiva Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.3.2 Cytiva Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.3.3 Cytiva Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Cytiva Main Business and Markets Served
7.3.5 Cytiva Recent Developments/Updates
7.4 Beyotime Biotechnology
7.4.1 Beyotime Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.4.2 Beyotime Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.4.3 Beyotime Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Beyotime Biotechnology Main Business and Markets Served
7.4.5 Beyotime Biotechnology Recent Developments/Updates
7.5 Multi Sciences
7.5.1 Multi Sciences Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.5.2 Multi Sciences Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.5.3 Multi Sciences Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Multi Sciences Main Business and Markets Served
7.5.5 Multi Sciences Recent Developments/Updates
7.6 Shanghai BasalMedia Technologies
7.6.1 Shanghai BasalMedia Technologies Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.6.2 Shanghai BasalMedia Technologies Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.6.3 Shanghai BasalMedia Technologies Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Shanghai BasalMedia Technologies Main Business and Markets Served
7.6.5 Shanghai BasalMedia Technologies Recent Developments/Updates
7.7 Tianjin Haoyang Biological Manufacture
7.7.1 Tianjin Haoyang Biological Manufacture Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.7.2 Tianjin Haoyang Biological Manufacture Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.7.3 Tianjin Haoyang Biological Manufacture Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Tianjin Haoyang Biological Manufacture Main Business and Markets Served
7.7.5 Tianjin Haoyang Biological Manufacture Recent Developments/Updates
7.8 Dakewe Biotech
7.8.1 Dakewe Biotech Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.8.2 Dakewe Biotech Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.8.3 Dakewe Biotech Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Dakewe Biotech Main Business and Markets Served
7.8.5 Dakewe Biotech Recent Developments/Updates
7.9 Guangzhou Jiance Biotechnology
7.9.1 Guangzhou Jiance Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.9.2 Guangzhou Jiance Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.9.3 Guangzhou Jiance Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Guangzhou Jiance Biotechnology Main Business and Markets Served
7.9.5 Guangzhou Jiance Biotechnology Recent Developments/Updates
7.10 CIDA (Guangzhou) Biotechnology
7.10.1 CIDA (Guangzhou) Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.10.2 CIDA (Guangzhou) Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.10.3 CIDA (Guangzhou) Biotechnology Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 CIDA (Guangzhou) Biotechnology Main Business and Markets Served
7.10.5 CIDA (Guangzhou) Biotechnology Recent Developments/Updates
7.11 TransGen Biotech
7.11.1 TransGen Biotech Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.11.2 TransGen Biotech Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.11.3 TransGen Biotech Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 TransGen Biotech Main Business and Markets Served
7.11.5 TransGen Biotech Recent Developments/Updates
7.12 Beijing SBS Genetech
7.12.1 Beijing SBS Genetech Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.12.2 Beijing SBS Genetech Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.12.3 Beijing SBS Genetech Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Beijing SBS Genetech Main Business and Markets Served
7.12.5 Beijing SBS Genetech Recent Developments/Updates
7.13 Beijing Solarbio Science & Technology
7.13.1 Beijing Solarbio Science & Technology Human Peripheral Blood Lymphocyte Separation Medium Company Information
7.13.2 Beijing Solarbio Science & Technology Human Peripheral Blood Lymphocyte Separation Medium Product Portfolio
7.13.3 Beijing Solarbio Science & Technology Human Peripheral Blood Lymphocyte Separation Medium Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Beijing Solarbio Science & Technology Main Business and Markets Served
7.13.5 Beijing Solarbio Science & Technology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Human Peripheral Blood Lymphocyte Separation Medium Industry Chain Analysis
8.2 Human Peripheral Blood Lymphocyte Separation Medium Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Human Peripheral Blood Lymphocyte Separation Medium Production Modes and Processes
8.4 Human Peripheral Blood Lymphocyte Separation Medium Sales and Marketing
8.4.1 Human Peripheral Blood Lymphocyte Separation Medium Sales Channels
8.4.2 Human Peripheral Blood Lymphocyte Separation Medium Distributors
8.5 Human Peripheral Blood Lymphocyte Separation Medium Customer Analysis
9 Human Peripheral Blood Lymphocyte Separation Medium Market Dynamics
9.1 Human Peripheral Blood Lymphocyte Separation Medium Industry Trends
9.2 Human Peripheral Blood Lymphocyte Separation Medium Market Drivers
9.3 Human Peripheral Blood Lymphocyte Separation Medium Market Challenges
9.4 Human Peripheral Blood Lymphocyte Separation Medium Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human Peripheral Blood Lymphocyte Separation Medium market is projected to grow from US$ 153 million in 2025 to US$ 215 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 167
USD 4900.00
(Single User License)
The global Human Peripheral Blood Lymphocyte Separation Medium market size was US$ 153 million in 2025 and is forecast to reach a readjusted size of US$ 215 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 92
USD 4250.00
(Single User License)
The global market for Human Peripheral Blood Lymphocyte Separation Medium was estimated to be worth US$ 153 million in 2025 and is projected to reach US$ 215 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 111
USD 3950.00
(Single User License)
The global Human Peripheral Blood Lymphocyte Separation Medium market is projected to grow from US$ 146 million in 2024 to US$ 206 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 165
USD 4900.00
(Single User License)
The global Human Peripheral Blood Lymphocyte Separation Medium market size was US$ 146 million in 2024 and is forecast to a readjusted size of US$ 206 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 95
USD 4250.00
(Single User License)
The global market for Human Peripheral Blood Lymphocyte Separation Medium was estimated to be worth US$ 146 million in 2024 and is forecast to a readjusted size of US$ 206 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 122
USD 3950.00
(Single User License)
The global market for Human Peripheral Blood Lymphocyte Separation Medium was valued at US$ 146 million in the year 2024 and is projected to reach a revised size of US$ 206 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-03-10
Pages: 103
USD 2900.00
(Single User License)
Valued at US$ 146 million in 2024, the global Human Peripheral Blood Lymphocyte Separation Medium market is forecast to reach US$ 197 million by 2030, at a CAGR of 5.1% during the forecast period.
Published Date: 2024-12-04
Pages: 160
USD 4900.00
(Single User License)
The global Human Peripheral Blood Lymphocyte Separation Medium revenue was US$ 132 million in 2023 and is forecast to a readjusted size of US$ 197 million by 2030 with a CAGR of 5.1% during the review period (2024-2030).
Published Date: 2024-12-04
Pages: 123
USD 4350.00
(Single User License)
The global market for Human Peripheral Blood Lymphocyte Separation Medium was estimated to be worth US$ 132 million in 2023 and is forecast to a readjusted size of US$ 197 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030.
Published Date: 2024-12-04
Pages: 111
USD 3950.00
(Single User License)
The global Human Peripheral Blood Lymphocyte Separation Medium market is projected to grow from US$ 153 million in 2025 to US$ 215 million by 2032, at a CAGR of 5.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 167
The global Human Peripheral Blood Lymphocyte Separation Medium market size was US$ 153 million in 2025 and is forecast to reach a readjusted size of US$ 215 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 92
The global market for Human Peripheral Blood Lymphocyte Separation Medium was estimated to be worth US$ 153 million in 2025 and is projected to reach US$ 215 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-08
Pages: 111
The global Human Peripheral Blood Lymphocyte Separation Medium market is projected to grow from US$ 146 million in 2024 to US$ 206 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 165
The global Human Peripheral Blood Lymphocyte Separation Medium market size was US$ 146 million in 2024 and is forecast to a readjusted size of US$ 206 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 95
The global market for Human Peripheral Blood Lymphocyte Separation Medium was estimated to be worth US$ 146 million in 2024 and is forecast to a readjusted size of US$ 206 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 122
The global market for Human Peripheral Blood Lymphocyte Separation Medium was valued at US$ 146 million in the year 2024 and is projected to reach a revised size of US$ 206 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-03-10
Pages: 103
Valued at US$ 146 million in 2024, the global Human Peripheral Blood Lymphocyte Separation Medium market is forecast to reach US$ 197 million by 2030, at a CAGR of 5.1% during the forecast period.
Published: 2024-12-04
Pages: 160
The global Human Peripheral Blood Lymphocyte Separation Medium revenue was US$ 132 million in 2023 and is forecast to a readjusted size of US$ 197 million by 2030 with a CAGR of 5.1% during the review period (2024-2030).
Published: 2024-12-04
Pages: 123
The global market for Human Peripheral Blood Lymphocyte Separation Medium was estimated to be worth US$ 132 million in 2023 and is forecast to a readjusted size of US$ 197 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030.
Published: 2024-12-04
Pages: 111
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now